Latest Breaking News On - Kristina hachey - Page 3 : comparemela.com

Theralase(R) Granted Canadian Cancer Vaccine Patent

TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the.

United statesKristina hacheyRoger dumoulin whiteArkady mandelAmerican cancer societyRegulation services providerTheralase technologies incA european unionCompany photo dynamic compoundsTechnologies incVenture exchangePhoto dynamic compoundsContaining cancer cells inactivatedPhotodynamic treatmentMetal based coordination complexesEuropean union

Theralase(R) Release s 4Q2023 Interim Financial Statements

Theralase(R) Release s 4Q2023 Interim Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioMichael jewettKristina hacheyCalmette guArkady mandelCompany photo dynamic compoundsHealth canadaBladder cancer forumDevice divisionCanadian urologic associationRegulation services providerDrug divisionAmerican urology associationVenture exchangeTheralase technologies inc

Theralase Technologies Inc : Theralase Release s 4Q2023 Interim Financial Statements

Theralase Technologies Inc : Theralase Release s 4Q2023 Interim Financial Statements
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan antonioKristina hacheyCalmette guArkady mandelDennis riedlMichael jewettCompany photo dynamic compoundsHealth canadaBladder cancer forumDevice divisionCanadian urologic associationTechnologies incTheralase technologies incAmerican urology associationVenture exchange

Theralase targets completion of Study II enrollment this year for bladder cancer treatment Rudivar

Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) is eyeing regulatory approval for its lead asset, the bladder cancer treatment Rudivar, by 2026,.

United statesSan antonioKristina hacheyHealth canadaCanadian urologic association bladder cancer forumTheralase technologies incDrug divisionAmerican urology associationUrology association

Theralase(R) to Host Advisory Board Meetings at Canadian Urological

Theralase(R) to Host Advisory Board Meetings at Canadian Urological .

United statesSan antonioCalmette guerinKristina hacheyNews networkAmerican urology associationTechnologies incVenture exchangeCanadian urological associationAmerican urological associationRegulation services providerBladder cancer forumCompany photo dynamic compoundsPhoto dynamic compoundsAdvisory boardPrincipal investigators